Survodutide

Survodutide is an investigational dual-agonist peptide used in metabolic research to study combined glucagon receptor (GCGR) and GLP-1 receptor signaling in obesity- and liver-disease biology models.

• Research class: Dual GCGR/GLP-1R agonist peptide (BI 456906) under clinical investigation.

• Primary research purpose: Evaluating multi-pathway metabolic signaling (appetite/energy-balance and hepatic-metabolic pathway interactions).

• Common research endpoints: Body-weight dynamics, glycemic/metabolic biomarkers, liver fat/inflammation measures, and fibrosis-related liver endpoints in obesity/MASH research programs.

For research use only. Not for therapeutic or diagnostic applications.